Mepolizumab Lessens Exacerbations, Improves Quality of Life

Mepolizumab Lessens Exacerbations, Improves Quality of Life

302336

Mepolizumab Lessens Exacerbations, Improves Quality of Life

Treatment with mepolizumab, an antibody designed to lower the levels of eosinophils — immune cells linked with worse chronic obstructive pulmonary disease (COPD) — was found to reduce the annual rate of exacerbations and improve health-related quality of life in people with eosinophil-associated COPD. The findings, from a meta-analysis of two clinical trials, support the potential benefits of mepolizumab for COPD patients with high levels of eosinophils. “Mepolizumab works in patients with COPD who have…

You must be logged in to read/download the full post.